Últimos testes

EudraCT Number: 2004-004321-95

Sponsor Protocol Number: AMLSG 07-04

Start Date: 2005-05-26

Sponsor Name: University of Ulm

Full Title: RANDOMIZED PHASE II-STUDY ON VALPROIC ACID, ALL-TRANS RETINOIC ACID AND THEIR COMBINATION IN INDUCTION AND CONSOLIDATION THERAPY AS WELL AS PEGFILGRASTIM AFTER CONSOLIDATION THERAPY IN YOUNGER PATI...

Medical condition: newly diagnosed acute myeloid leukemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: AT (Ongoing)

Trial results: View results

EudraCT Number: 2004-005088-17

Sponsor Protocol Number: CZOL446EHU03

Start Date: 2005-05-26

Sponsor Name: Novartis Hungária Ltd.

Full Title: A multicenter, Open-label Study to Determine the Effect of I.V. Zometa on Pain and Quality of Life in Patients with Bone Metastases with or without Skeletal Related Events (SREs) Resulting from Bre...

Medical condition: Patients will have bone metastases with or without skeletal related events (SREs) from breast cancer and prostate cancer.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed)

Trial results: View results

EudraCT Number: 2004-004921-89

Sponsor Protocol Number: 1315

Start Date: 2005-05-25

Sponsor Name: North Bristol NHS Trust

Full Title: Improving diagnosis and treatment of attention deficits in head injured patients

Medical condition: Attention difficulties after closed head injury

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2005-001971-36

Sponsor Protocol Number: RETAANE PED

Start Date: 2005-05-25

Sponsor Name: OSPEDALE S. RAFFAELE

Full Title: PILOT, OPEN NON COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICAY AND SAFETY OF RETAANE (ANECORTAVE ACETATO 15 MG, 0.5 ML DI 30 MG/ML ANECORTAVE ACETATO STERILE SUSPENSION) IN PATIENTS WITH COROID...

Medical condition: RETAANE TREATMENT OF COROIDEAL NEOVASCULARIZATION FORMS SECONDARY TO SENILE MACULAR DEGENERATION

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10015919		SOC

Population Age: Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2005-000619-85

Sponsor Protocol Number: 2937

Start Date: 2005-05-25

Sponsor Name: The University of Liverpool [...] 1. The University of Liverpool 2. The Royal Liverpool and Broadgreen University Hospitals NHS Trust

Full Title: The relationship between genetic polymorphisms in the organic cation transporter genes and the pharmacokinetics and pharmacodynamics of metformin

Medical condition: Type 2 diabetes mellitus

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2005-000333-38

Sponsor Protocol Number: Hcy2005

Start Date: 2005-05-25

Sponsor Name: Organisation name was not entered

Full Title: A randomized placebo-controlled trial to investigate blood pressure lowering effects of folic acid in patients with borderline hypertension.

Medical condition: Patients with hyperhomocysteinemia and high-normal blood pressure, otherwise healthy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003754-26

Sponsor Protocol Number: NV-02B-019

Start Date: 2005-05-25

Sponsor Name: Idenix Pharmaceuticals, Inc.

Full Title: A Randomized Trial of Switching Antiviral Therapy from Lamivudine to Telbivudine (LdT) vs. Continued Lamivudine Treatment in Adults with Chronic Hepatitis B

Medical condition: chronic hepatitis B

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-004799-35

Sponsor Protocol Number: DRI5349

Start Date: 2005-05-25

Sponsor Name: Sanofi-aventis recherche and developpement

Full Title: Double blind placebo controlled dose ranging study of the efficacy and safety of SSR149744C 100 or 300 mg for the prevention of ventricular arrhythmia-triggered ICD interventions

Medical condition: Ventricular arrhythmia triggered ICD interventions

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10003131		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) DE (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2004-004721-10

Sponsor Protocol Number:

Start Date: 2005-05-25

Sponsor Name: Sussex NHS Research Consortium, Research Department, Worthing Hospital

Full Title:

Medical condition: Proximal femoral fracture

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2005-000374-48

Sponsor Protocol Number: 104325

Start Date: 2005-05-25

Sponsor Name: GlaxoSmithKline Pharma A/S

Full Title: A randomized, open label comparative study to determine the proportion of asthma patients on Seretide Diskus 50/250 mcg b.i.d. achieving total control when given medication and compli-ance enhancem...

Medical condition: Asthma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: View results

Últimos testes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas